Skip to main content
Login
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

AstraZeneca Files for US FDA Approval of HUTCHMED Lung Cancer Drug Combination

Summary by WTVB
Sept 29 (Reuters) - HUTCHMED (China) said on Tuesday that Anglo-Swedish drugmaker AstraZeneca had ​applied to the ‌US Food and Drug Administration for approval of the ORPATHYS-TAGRISSO combination to treat patients with ‌advanced ​lung cancer. ORPATHYS...

2 Articles

WTVBWTVB
Center

AstraZeneca files for US FDA approval of HUTCHMED lung cancer drug combination

Sept 29 (Reuters) - HUTCHMED (China) said on Tuesday that Anglo-Swedish drugmaker AstraZeneca had ​applied to the ‌US Food and Drug Administration for approval of the ORPATHYS-TAGRISSO combination to treat patients with ‌advanced ​lung cancer. ORPATHYS...

Read Full Article
BizTocBizToc

AstraZeneca files US FDA application for HUTCHMED lung cancer drug combination

The Entire Business World on a Single Page with the Web's Most Comprehensive One-Stop Finance News Hub.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

WTVB broke the news on Tuesday, September 29, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

AstraZeneca icon

AstraZeneca

United States icon

United States

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal